From soda bottles to car bumpers to piping, electronics, and packaging, plastics have become a ubiquitous part of our lives.
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
A multi-institutional team, led by a group of investigators at 91°µÍø, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease.
Seven ORNL scientists have been named among the 2020 Highly Cited Researchers list, according to Clarivate, a data analytics firm that specializes in scientific and academic research.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s 91°µÍø that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
Scientists from 91°µÍø used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.
Popular wisdom holds tall, fast-growing trees are best for biomass, but new research by two U.S. Department of Energy national laboratories reveals that is only part of the equation.
Four research teams from the Department of Energy’s 91°µÍø and their technologies have received 2020 R&D 100 Awards.
The combination of bioenergy with carbon capture and storage could cost-effectively sequester hundreds of millions of metric tons per year of carbon dioxide in the United States, making it a competitive solution for carbon management, according to a new